PDUFA Calendar

Advisory Committee

About the author

Currently residing in New Zealand and employed in the education industry, Mr. A. Burden holds a M.Com in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.

48 Responses to “PDUFA Calendar”

  1. Daniel says:

    I am a very happy visitor of your site. You have one of the most refined calendars out there, and i’m grateful of the hard work you do. I’d love to contribute to you if you have a paypal or another link. Also, do you have a google calendar, or a RSS feed for the calendar available?

  2. admin says:

    Thanks for the feedback Daniel. Donations are most appreciated. As luck would have it I have a DONATE button on all pages except this page! You’ll find it as a green button. All additions to the calendar are noted in the title when I post an article and there is a RSS feed available. However, I haven’t got one set up just for the calendar. If you’re on twitter I also tweet out new PDUFA dates. Unfortunately no google calendar.

  3. Nilesh Patel says:

    Really appreciate the hard work in accumulating the details and arranging in orderly fashion.

  4. Ben says:

    Hi. there are some PDUFA dates in August that are missing from the calendar.

  5. Ben says:

    Sorry, only one – PDUFA set for 27 August 2012 for Gilead’s Quad HIV pill.

    Thanks for the great job.

    • admin says:

      Thanks Ben. Done. I generally only keep an eye on stocks sub $25, hence the reason for GILD not being on the calendar. Nothing against large-cap companies, but I have to draw the line somewhere to manage my workload…but of course if I hear of a PDUFA date from a reader that I haven’t listed then I will most certainly add it to the calendar!

  6. Brian says:

    The Smaller caps have higher returns. More shares for your money.

  7. leo says:

    why do you delete old events?

    • admin says:

      Hi Leo. The PDUFA calendar is set up so that all PDUFA/Advisory Committee dates are AUTOMATICALLY entered from information that I manually enter into the FDA Calendar. I made the decision to delete events from the FDA Calendar hoping to make it easier for investors to determine which events/catalysts were yet to occur and the FDA Calendar would no doubt become too full of unwanted information. This was primarily aimed at companies with upcoming clinical data releases or trial initiations. The FDA Calendar is primarily sorted by date with upcoming events at the top of the calendar to make it easier for investors to use. The downside to this is that past events are also removed from the PDUFA Calendar. In the previous version of the website (up until Dec ’11) previous PDUFA events were kept in the PDUFA Calendar, which was back then manually maintained. I’d like to keep the “automatic” updating feature of the PDUFA Calendar as it saves me much needed time, rather than “manually” updating it. I’m not sure if there’s a way around it but will investigate further.

      For your information, past PDUFA results are included in the Clinical Database.

  8. pat says:

    you are missing May 29th Cipher Pharms (DND.to) PDUFA date

  9. Stevo says:

    I noticed that the press release for DVAX for Feb “24″ 2013 and you have it listed as “26″.

    Thanks for the calender.

    • admin says:


      Thanks very much for pointing the error out. It is much appreciated!

      I have fixed the error in both the FDA and PDUFA Calendars.

  10. Nick says:

    I believe you are missing EXEL’s cabo expecting a decision on November 30th.

    • admin says:


      I understand they sought priority review when they filed their NDA in May, which would result in a late Nov PDUFA date, but to my knowledge they haven’t heard back from the FDA. I haven’t seen it PR’d. Have you heard differently? I expect them to hear back from the FDA at the end of this month.

  11. Omar says:

    really appreciate your work amazing job, but i am new to this can you tell me where i to start reading about how to use this staff in good and correct way will be V.thankful

    really impressed

    • admin says:


      Sorry about the delay in getting back to you. The latest week has been very busy.

      There is no simple answer to your question unfortunately. In general terms, the aim is to identify a clinical catalyst and the likely result. If you’re new it’ll be easier to follow stocks with upcoming PDUFA dates and monitor the price behaviour leading up to the PDUFA date and action following the FDA decision.

  12. Anat says:

    You need to add HEB PDUFA in Feb.

  13. Tiran says:

    Great website!!
    CRTX recived approval on the 18/10 not 29/10.
    Can I have historical data since 2005?


  14. Upcoming BioPharma Catalyst Trades to Consider | StockMatusow.com says:

    [...] FDA Decision is expected on November 30th for its supplemental New Drug Application (SNDA) to the US FDA for Promacta (eltrombopag) as a [...]

  15. joe says:

    Best Site for Bio stocks!

  16. Name says:

    Great site!
    Many thanks.

  17. Nilesh Patel says:

    pdufa-calendar calendar seems to be broken. today.

    • admin says:

      Thanks for letting me know Nilesh. I will need to contact my webmaster regarding this as it seems to be quite a complex issue.

      Apologies for the inconvenience caused. Meanwhile, please refer to the FDA Calendar for PDUFA and Adcom dates.

    • admin says:

      Problem has been fixed. Should be working now. Thank you for your patience.

  18. Jamal Shirazi says:

    Great site,did you miss “DEPO” PDUFA date 0n 05/31/13 ,I read it somewhere,may be I am wrong.

  19. Jamal says:

    What do you think about AVEO approval chances on 07/28/13 ?

    • admin says:

      Very little chance of approval IMO. It’ll be the FDA Approval surprise of the decade if they get approval. They will have to conduct new trials and refile at a later date.

  20. Jamal says:

    I don’t see any PDUFA date for RMTI, they have successfully completed Phase 3 studies now,any idea on approval date?

  21. Jamal says:

    What are the Approval chances of DCTH and SGEN on 9/13/13 and 9/14/3,any comments?

  22. andre says:

    You might be missing a ADCOM and PDUFA for Lemtrada, Here is the news.

    FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will meet on Nov. 13-14 to discuss Lemtrada alemtuzumab from the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY). The PDUFA date is in 4Q13, but the exact date is not disclosed. The European Commission approved Lemtrada last month.

    • admin says:

      Thanks Andre,

      I generally concentrate on small-mid cap companies so don’t follow large cap companies in detail. However, the Adcom event is definitely worth a listing so it has been put up. I have held off listing the PDUFA date as my calendar requires an exact date in order to be listed.



  23. andre says:

    It looks that the ADCOM for Northera on Jan 14, 2014 is missing.
    Here is the news:
    Chelsea Therapeutics International, Ltd. (CHTP) announced that the Cardiovascular and Renal Drug Advisory Committee of the U.S. Food and Drug Administration (:FDA) will review the New Drug Application (:NDA) filed for Northera in Jul 2013. The meeting is scheduled to take place on Jan 14, 2014.

  24. Jamal says:

    I think you are missing PDUFA date for GTHP, did you forget to put it or there is no date available?

  25. Han Neumann says:

    Do the FDA meetings for approvel and advisory mostly start at a specific time of the day, f.e. 10:00 am. ET ?

  26. Han Neumann says:

    That site doesn’t mention details like start ‘time of the day’. Maybe when signing up for updates on that site you get it. I will try to find out.

Leave a Reply